Journal of Virological Methods 1992: Vol 38 Index

8 Pages·1992·1.5 MB·English

Author Index
Ahluwalia, G., see Scott-Taylor, T.H., 25 Doerr, W., see Weber, B., 187
Andrei, G., see Snoeck, R., 243 Domdey, H., see Giesecke, H., 47
Dominguez, J., see Laviada, M.D., 229
Babin, M., see Laviada, M.D., 229 Douville, C., see Robbins, D., 267
Bartolomé, J., see Castillo, I., 71 Downing, L.A., Bernstein, J.M. and Walter, A.,
Bernstein, J.M., see Downing, L.A., 215 Active respiratory syncytial virus purified by ion
Bidawid-Woodroffe, S., Sullivan-Tailyour, G., exchange chromatography: characterization of
Roig-Farran, P. and Garnett, H.M., Increased binding and elution requirements, 215
cytomegalovirus infection of human fibroblast
and endothelial cells by electroporation, 167 Fehr, J., see Schlayer, H.-J., 333
Briggs, M., see Coyle, P.V., 283 Fox, J.D., see Coyle, P.V., 283
Brock, K.V., Deng, R. and Riblet, S.M., Nucleo-
tide sequencing of 5’ and 3’ termini of bovine viral Gallinella, G., see Musiani, M., 1
diarrhea virus by RNA ligation and PCR, 39 Garnett, H.M., see Bidawid-Woodroffe, S., 167
Gentilomi, G., see Musiani, M., 1
Cabal, C.M., see Dawson, G.J., 175 Gerok, W., see Schlayer, H.-J., 333
Cardon, M.C., see Hartig, P.C., 61 Gibellini, D., see Musiani, M., 1
Carreno, V., see Castillo, I., 71 Giesecke, H., Obermaier, B., Domdey, H. and
Castillo, I., Bartolome, J., Quiroga, J.A. and Neubert, W.J., Rapid sequencing of the Sendai
Carreho, V., Comparison of several PCR virus 6.8 kb large (L) gene through primer
procedures for detection of serum HCV-RNA walking with an automated DNA sequencer, 47
using different regions of the HCV genome, 71 Goldbach, R.W., see Kitajima, E.W., 313
Chang, G.-J., see Lewis, J.G., 11 Gowans, E., see Sumathy, S., 145
Chang, Y.S., see Shu, C.H., 123 Gracey, D., see Robbins, D., 267
Chang, P., see Shu, C.H., 123 Groene, W.S. and Shaw, R.D., Psoralen prepara-
Chargelegue, D. and O’Toole, C.M., Development tion of antigenically intact noninfectious rota-
of a sensitive ELISA for HIV-1 p24 antigen virus particles, 93
using a fluorogenic substrate for monitoring
HIV-1 replication in vitro, 323 Hammond, G.W., see Scott-Taylor, T.H., 25
Chau, K.H., see Dawson, G.J., 175 Harms, F., see Weber, B., 187
Christian, P.D., A simple vacuum dot-blot hybri- Hartig, P.C. and Cardon, M.C., Rapid efficient
disation assay for the detection of Drosophila A production of baculovirus expression vectors, 61
and C viruses in single Drosophila, 153 Hase, A., see Nakagami, T., 255
Cloes, J.M., see Snoeck, R., 243 Healey, D.S. and Dax, E.M., An evaluation of two
Coleman, C., see Robbins, D., 267 simple synthetic peptide based anti-HIV assays,
Coyle, P.V., Briggs, M., Tedder, R.S. and Fox, 305
J.D., Comparison of three immunoassays for the
detection of anti-HHV6, 283 Jiang, M., Parniak, M.A. and Kleiman, L.,
Isolation and fractionation of retroviral
Dawson, G.J., Chau, K.H., Cabal, C.M., Yar- tRNAs, 205
bough, P.O., Reyes, G.R. and Mushahwar, I.K., Jin, L., see Scherba, G., 131
Solid-phase enzyme-linked immunosorbent as-
say for hepatitis E virus IgG and IgM antibodies Kano, T., see Suzuki, K., 113
utilizing recombinant antigens and _ synthetic Kimura, T., see Nakagami, T., 255
Kitajima, E.W., Resende, R. de O., de Avila, A.C.,
peptides, 175
Dax, E.M., see Healey, D.S., 305 Goldbach, R.W. and Peters, D., Immuno-
de Avila, A.C., see Kitajima, E.W., 313 electron microscopical detection of tomato
De Clercq, E., see Snoeck, R., 243 spotted wilt virus and its nucleocapsids in crude
Deng, R., see Brock, K.V., 39 plant extracts, 313
348
Kleiman, L., see Jiang, M., 205 Peters, D., see Kitajima, E.W., 313
Knisley, K., see Oleszak, E.L., 103 Peters, T., see Schlayer, H.-J., 333
Kuramoto, I.K., see Robbins, D., 267 Piette, J., see Snoeck, R., 243
Preisler, S., see Schlayer, H.-J., 333
Lanciotti, R.S., see Lewis, J.G., 11
La Placa, M., see Musiani, M., 1 Quiroga, J.A., see Castillo, I., 71
Latif, R., see Sumathy, S., 145
Laviada, M.D., Babin, M., Dominguez, J. and Raguram, K., see Sumathy, S., 145
Sanchez-Vizcaino, J.M., Detection of African Rajasambandam, P., see Sumathy, S., 145
horsesickness virus in infected spleens by a Rasenack, J., see Schlayer, H.-J., 333
sandwich ELISA using two monoclonal anti- Rentier, B., see Snoeck, R., 243
bodies specific for VP7, 229 Resende, R. de O., see Kitajima, E.W., 313
Lee, L.H., Characterization of nonradioactive Reyes, G.R., see Dawson, G.J., 175
hybridization probes for detecting infectious Riblet, S.M., see Brock, K.V., 39
bursal disease virus, 81 Robbins, D., Wright, T., Coleman, C., Umhoefer,
Leibowitz, J.L., see Oleszak, E.L., 103 L., Moore, B., Spronk, A., Douville, C.,
Lewis, J.G., Chang, G.-J., Lanciotti, R.S. and Kuramoto, I.K., Rynning, M., Gracey, D.,
Trent, D.W., Direct sequencing of large flavi- Salbilla, V., Nehmadi, F. and Mimms, L.T.,
virus PCR products for analysis of genome Serological detection of HBeAg and anti-HBe
variation and molecular epidemiological investi- using automated microparticle enzyme immu-
gations, 11 noassays, 267
Liang, C.L., see Shu, C.H., 123 Rodkey, L.S., see Oleszak, E.L., 103
Lin, C.Z., see Shu, C.H., 123 Roig-Farran, P., see Bidawid-Woodroffe, S., 167
Liu, S.T., see Shu, C.H., 123 Rynning, M., see Robbins, D., 267
Lorenzen, N., Affinity purification of the structural
proteins of a fish Rhabdovirus by the use of Sadzot-Delvaux, C., see Snoeck, R., 243
monoclonal antibodies, 297 Salbilla, V., see Robbins, D., 267
Sanchez-Vizcaino, J.M., see Laviada, M.D., 229
Madanagopalan, N., see Sumathy, S., 145 Scherba, G., Jin, L., Schnitzlein, W.M. and
Mimms, L.T., see Robbins, D., 267 Vodkin, M.H., Differential polymerase chain
Moore, B., see Robbins, D., 267 reaction for detection of wild-type and a vaccine
Mushahwar, I.K., see Dawson, G.J., 175 strain of Aujeszky’s disease (pseudorabies) virus,
Musiani, M., Zerbini, M., Gentilomi, G., Gibellini, 131
D., Gallinella, G., Venturoli, S. and La Placa, Schlayer, H.-J., Peters, T., Preisler, S., Fehr, J.,
M., Detection of CMV DNA in clinical samples Gerok, W. and Rasenack, J., Amplification of
of AIDS patients by chemiluminescence hybri- unknown DNA sequences by sequence-indepen-
dization, 1 dent nested polymerase chain reaction using a
standardized adaptor without specific primers,
Nakagami, T., Shigehisa, T., Ohmori, T., Taji, S., 333
Hase, A., Kimura, T. and Yamanishi, K.., Schnitzlein, W.M., see Scherba, G., 131
Inactivation of herpes viruses by high hydro- Schols, D., see Snoeck, R., 243
static pressure, 255 Scott-Taylor, T.H., Ahluwalia, G. and Hammond,
Nehmadi, F., see Robbins, D., 267 G.W., Restriction analysis of the prototype
Neubert, W.J., see Giesecke, H., 47 strain of enteric adenovirus type 41 using
exonuclease III, 25
Obermaier, B., see Giesecke, H., 47 Selb, B., see Weber, B., 187
Ohmori, T., see Nakagami, T., 255 Shaw, R.D., see Groene, W.S., 93
Okamoto, N., see Suzuki, K., 113 Shigehisa, T., see Nakagami, T., 255
Oleszak, E.L., Knisley, K., Rodkey, L.S. and Shu, C.H., Chang, Y.S., Liang, C.L., Liu, S.T., Lin,
Leibowitz, J.L., Microheterogeneity of S-glyco- C.Z. and Chang, P., Distribution of type A and
protein of mouse hepatitis virus temperature- type B EBV in normal individuals and patients
sensitive mutants, 103 with head and neck carcinomas in Taiwan, 123
Olivo, P.D., see Stabell, E.C., 195 Snoeck, R., Schols, D., Sadzot-Delvaux, C., Cloes,
O’Toole, C.M., see Chargelegue, D., 323 J.M., Andrei, G., De Clercq, E., Piette, J. and
Parniak, M.A., see Jiang, M., 205 Rentier, B., Flow cytometric method for the
detection of gpI antigens of Varicella zoster virus Thyagarajan, S.P., see Sumathy, S., 145
and evaluation of anti-VZV agents, 243 Trent, D.W., see Lewis, J.G., 11
Spronk, A., see Robbins, D., 267
Stabell, E.C. and Olivo, P.D., Isolation of a cell line Umhoefer, L., see Robbins, D., 267
for rapid and sensitive histochemical assay for
the detection of herpes simplex virus, 195 Venturoli, S., see Musiani, M., 1
Sullivan-Tailyour, G., see Bidawid-Woodroffe, S., Vodkin, M.H., see Scherba, G., 131
167
Sumathy, S., Thyagarajan, S.P., Latif, R., Mada- Walter, A., see Downing, L.A., 215
nagopalan, N., Raguram, K., Rajasambandam, Watanabe, S., see Suzuki, K., 113
P. and Gowans, E., A dipstick immunobinding Weber, B., Harms, F., Selb, B. and Doerr, W.,
enzyme-linked immunosorbent assay for sero- Improvement of rotavirus isolation in the cell
diagnosis of hepatitis B and delta virus infec- culture by immune peroxidase staining, 187
tions, 145 Wright, T., see Robbins, D., 267
Suzuki, K., Okamoto, N., Watanabe, S. and Kano,
T., Chemiluminescent microtiter method for Yamanishi, K., see Nakagami, T., 255
detecting PCR amplified HIV-1 DNA, 113 Yarbough, P.O., see Dawson, G.J., 175
Taji, S., see Nakagami, T., 255 Zerbini, M., see Musiani, M., 1
Tedder, R.S., see Coyle, P.V., 283

Subject Index
a-Galactosidase, Herpes simplex virus, Diagnosis, Particle agglutination, Sensitivity, Specificity,
Histochemistry, 195 305
AIDS patients, Cytomegalovirus DNA, Chemilu- Chemiluminescence assay, Cytomegalovirus DNA,
minescence assay, | AIDS patients, |
Acyclovir, Varicella zoster virus, Monoclonal anti- Chemiluminescence, HIV, PCR, Microtiter, Solu-
body, Flow cytometry, Antiviral activity assay, tion hybridization, 113
Bromovinyldeoxyuridine, 243 Chronic hepatitis C,H CV RNA, PCR, 71
Affinity purification, VHS virus protein, Solubiliza- Circle immunoassay, Human herpesvirus 6, Com-
tion, Antibody elution, Direct immunoprecipita- petitive RIA, 283
tion, 297 Column chromatography, Mouse mammary tumor
African horsesickness virus, Monoclonal antibodies, virus, tRNA fractionation, 205
ELISA, Diagnosis, 229 Competitive RIA, Human herpesvirus 6, Circle
Anti-HIV assay, Evaluation, Particle agglutination, immunoassay, 283
Cartridge assay, Sensitivity, Specificity, 305 Conventional enzyme-linked immunosorbent assay,
Anti-hepatitis B e, Hepatitis B, Enzyme immunoas- Dipstick immunobinding—enzyme-linked immu-
say, Hepatitis B e antigen, Hepatitis B c antigen, nosorbent assay, Hepatitis B surface antigen,
267 Hepatitis delta antigen, 145
Antibody elution, VHS virus protein, Solubilization, Conventional virus isolation, Immunoperoxidase
Direct immunoprecipitation, Affinity purifica- staining (IPS), Infectivity assay, ELISA, 187
tion, 297 Cytomegalovirus DNA, AIDS patients, Chemilumi-
Antigen, HIV-1 p24, ELISA, Fluorescence, p- nescence assay, |
Galactosidase, 323 Defective particle, Tomato spotted wilt virus,
Antiviral activity assay, Varicella zoster virus, Immunogold labelling, 313
Monoclonal antibody, Flow cytometry, Acyclo- Dengue, Polymerase chain reaction (PCR), Sequen-
vir, Bromovinyldeoxyuridine, 243 cing, 11
Aujeszky’s disease (pseudorabies) virus, Differential Diagnosis, Herpes simplex virus, «-Galactosidase,
polymerase chain reaction, Aujeszky’s disease Histochemistry, 195
(pseudorabies) virus gX gene, Pseudorabies virus Diagnosis, African horsesickness virus, Monoclonal
gX PCR, 131 antibodies, ELISA, 229
Aujeszky’s disease (pseudorabies) virus gX gene, Differential polymerase chain reaction, Aujeszky’s
Aujeszky’s disease (pseudorabies) virus, Differ- disease (pseudorabies) virus, Aujeszky’s disease
ential polymerase chain reaction, Pseudorabies (pseudorabies) virus gX gene, Pseudorabies virus
virus gX PCR, 131 gX PCR, 131
Autographa californica, Baculovirus, Expression Dipstick immunobinding—enzyme-linked immunosor-
vector, 61 bent assay, Hepatitis B surface antigen, Hepatitis
Automated DNA sequencing, Sendai virus, L gene, delta antigen, Conventional enzyme-linked im-
Primer walking, Fluorescent dyeterminators, 47 munosorbent assay, 145
Direct immunoprecipitation, VHS virus protein,
B-Galactosidase, HIV-1 p24, Antigen, ELISA, Solubilization, Antibody elution, Affinity pur-
Fluorescence, 323 ification, 297
Baculovirus, Autographa californica, Expression Dot-blot hybridisation assay, Drosophila C virus,
vector, 61 Drosophila A virus, 153
Bovine viral diarrhea virus, RNA ligation, Terminal Drosophila A virus, Drosophila C virus, Dot-blot
nucleotide sequence, Pestivirus, PCR, 39 hybridisation assay, 153
Bromovinyldeoxyuridine, Varicella zoster virus, Drosophila C virus, Drosophila A virus, Dot-blot
Monoclonal antibody, Flow cytometry, Antivir- hybridisation assay, 153
al activity assay, Acyclovir, 243
EBNA 2, Epstein-Barr virus, Nasopharyngeal
Cartridge assay, Anti-HIV assay, Evaluation, carcinoma, Polymerase chain reaction, 123
352
ELISA, Immunoperoxidase staining (IPS), Infec- virus, Hepatitis E virus synthetic peptides,
tivity assay, Conventional virus isolation, 187 Hepatitis E virus IgG and IgM antibodies, 175
ELISA, African horsesickness virus, Monoclonal Hepatitis E virus synthetic peptides, Hepatitis E
antibodies, Diagnosis, 229 virus, Hepatitis E virus recombinant antigens,
ELISA, HIV-1 p24, Antigen, Fluorescence, p- Hepatitis E virus IgG and IgM antibodies, 175
Galactosidase, 323 Hepatitis delta antigen, Dipstick immunobinding—
Electroporation, Human cytomegalovirus, Infectiv- enzyme-linked immunosorbent assay, Hepatitis
ity, 167 B surface antigen, Conventional enzyme-linked
Enteric adenovirus type 41, Restriction analysis, immunosorbent assay, 145
Exonuclease III, 25 Herpes simplex virus, Diagnosis, «-Galactosidase,
Enveloped virus, High hydrostatic pressure, Herpes Histochemistry, 195
virus, HSV-1, HCMV, 255 Herpes virus, High hydrostatic pressure, HSV-1,
Enzyme immunoassay, Hepatitis B, Hepatitis B e HCMYV, Enveloped virus, 255
antigen, Hepatitis B c antrgen, Anti-hepatitis B e, High hydrostatic pressure, Herpes virus, HSV-1,
267 HCMYV, Enveloped virus, 255
Epstein-Barr virus, EBNA 2, Nasopharyngeal Histochemistry, Herpes simplex virus, Diagnosis, «-
carcinoma, Polymerase chain reaction, 123 Galactosidase, 195
Evaluation, Anti-HIV assay, Particle agglutination, HIV, PCR, Chemiluminescence, Microtiter, Solu-
Cartridge assay, Sensitivity, Specificity, 305 tion hybridization, 113
Exonuclease III, Restriction analysis, Enteric HIV-1 p24, Antigen, ELISA, Fluorescence, p-
adenovirus type 41, 25 Galactosidase, 323
Expression vector, Baculovirus, Autographa cali- HSV-1, High hydrostatic pressure, Herpes virus,
fornica, 61 HCMYV, Enveloped virus, 255
Human cytomegalovirus, Infectivity, Electropora-
Flow cytometry, Varicella zoster virus, Monoclonal tion, 167
antibody, Antiviral activity assay, Acyclovir, Human herpesvirus 6, Competitive RIA, Circle
Bromovinyldeoxyuridine, 243 immunoassay, 283
Fluorescence, HIV-1 p24, Antigen, ELISA, f-
Galactosidase, 323 IBDV RNA detection, Infections bursal disease
Fluorescent dyeterminators, Sendai virus, L gene, virus (IBDV), Nonradiolabeled hybridization
Primer walking, Automated DNA sequencing, probe, 81
47 Immunogold labelling, Tomato spotted wilt virus,
Defective particle, 313
HCMYV, High hydrostatic pressure, Herpes virus, Immunoperoxidase staining (IPS), Infectivity assay,
HSV-1, Enveloped virus, 255 Conventional virus isolation, ELISA, 187
HCV RNA, Chronic hepatitis C, PCR, 71 Infections bursal disease virus (IBDV), Nonradiola-
Hepatitis B, Enzyme immunoassay, Hepatitis B e beled hybridization probe, IBDV RNA detec-
antigen, Hepatitis B c antigen, Anti-hepatitis B e, tion, 81
267 Infectivity, Human cytomegalovirus, Electropora-
Hepatitis B c antigen, Hepatitis B, Enzyme tion, 167
immunoassay, Hepatitis B e antigen, Anti- Infectivity assay, Immunoperoxidase staining (IPS),
hepatitis B e, 267 Conventional virus isolation, ELISA, 187
Hepatitis B e antigen, Hepatitis B, Enzyme
immunoassay, Hepatitis B c antigen, Anti- L gene, Sendai virus, Primer walking, Automated
hepatitis B e, 267 DNA sequencing, Fluorescent dyeterminators,
Hepatitis B surface antigen, Dipstick immunobind- 47
ing—enzyme-linked immunosorbent assay, Hepa-
titis delta antigen, Conventional enzyme-linked Microtiter, HIV, PCR, Chemiluminescence, Solu-
immunosorbent assay, 145 tion hybridization, 113
Hepatitis E virus, Hepatitis E virus recombinant Monoclonal antibodies, African horsesickness virus,
antigens, Hepatitis E virus synthetic peptides, ELISA, Diagnosis, 229
Hepatitis E virus IgG and IgM antibodies, 175 Monoclonal antibody, Varicella zoster virus, Flow
Hepatitis E virus IgG and IgM antibodies, Hepatitis cytometry, Antiviral activity assay, Acyclovir,
E virus, Hepatitis E virus recombinant antigens, Bromovinyldeoxyuridine, 243
Hepatitis E virus synthetic peptides, 175 Mouse hepatitis virus, 103
Hepatitis E virus recombinant antigens, Hepatitis E Mouse mammary tumor virus, tRNA fractionation,
353
Column chromatography, 205 independent amplification, Virus mutation, 333
Nasopharyngeal carcinoma, Epstein-Barr virus, Sendai virus, L gene, Primer walking, Automated
EBNA 2, Polymerase chain reaction, 123 DNA sequencing, Fluorescent dyeterminators,
Nonradiolabeled hybridization probe, Infections 47
bursal disease virus (IBDV), IBDV RNA Sensitivity, Anti-HIV assay, Evaluation, Particle
detection, 81 agglutination, Cartridge assay, Specificity, 305
Sequence-independent amplification, Polymerase
Particle agglutination, Anti-HIV assay, Evaluation, chain reaction, Virus mutation, Screening, 333
Cartridge assay, Sensitivity, Specificity, 305 Sequencing, Dengue, Polymerase chain reaction
PCR, Bovine viral diarrhea virus, RNA ligation, (PCR), 11
Terminal nucleotide sequence, Pestivirus, 39 Solubilization, VHS virus protein, Antibody elu-
PCR, Chronic hepatitis C,H CV RNA, 71 tion, Direct immunoprecipitation, Affinity pur-
PCR, HIV, Chemiluminescence, Microtiter, Solu- ification, 297
tion hybridization, 113 Solution hybridization, HIV, PCR, Chemilumines-
Pestivirus, Bovine viral diarrhea virus, RNA cence, Microtiter, 113
ligation, Terminal nucleotide sequence, PCR, 39 Specificity, Anti-HIV assay, Evaluation, Particle
Polymerase chain reaction, Epstein-Barr virus, agglutination, Cartridge assay, Sensitivity, 305
EBNA 2, Nasopharyngeal carcinoma, 123
Polymerase chain reaction, Sequence-independent Terminal nucleotide sequence, Bovine viral diarrhea
amplification, Virus mutation, Screening, 333 virus, RNA ligation, Pestivirus, PCR, 39
Polymerase chain reaction (PCR), Dengue, Sequen- Tomato spotted wilt virus, Defective particle,
cing, 11 Immunogold labelling, 313
Primer walking, Sendai virus, L gene, Automated tRNA fractionation, Mouse mammary tumor virus,
DNA sequencing, Fluorescent dyeterminators, Column chromatography, 205
47
Protein purification, Respiratory syncytial virus,
Varicella zoster virus, Monoclonal antibody, Flow
Vesicular stomatitis virus, Viral purification, 215 cytometry, Antiviral activity assay, Acyclovir,
Pseudorabies virus gX PCR, Aujeszky’s disease
Bromovinyldeoxyuridine, 243
(pseudorabies) virus, Differential polymerase Vesicular stomatitis virus, Respiratory syncytial
chain reaction, Aujeszky’s disease (pseudora- virus, Viral purification, Protein purification,
bies) virus gX gene, 131 215
Psoralen, Viral inactivation, Rotavirus, 93 VHS virus protein, Solubilization, Antibody elu-
tion, Direct immunoprecipitation, Affinity pur-
Respiratory syncytial virus, Vesicular stomatitis
ification, 297
virus, Viral purification, Protein purification, Viral inactivation, Psoralen, Rotavirus, 93
215 Viral purification, Respiratory syncytial virus,
Restriction analysis, Enteric adenovirus type 41, Vesicular stomatitis virus, Protein purification,
Exonuclease III, 25 215
RNA ligation, Bovine viral diarrhea virus, Terminal Virus mutation, Polymerase chain reaction, Se-
nucleotide sequence, Pestivirus, PCR, 39 quence-independent amplification, Screening,
Rotavirus, Psoralen, Viral inactivation, 93 333
Screening, Polymerase chain reaction, Sequence-